about
Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathyThe ubiquitin-proteasome system and cardiovascular diseaseCardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy PhenotypeMYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correctionHypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation.Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies.Rapid molecular genetic diagnosis of hypertrophic cardiomyopathy by semiconductor sequencing.Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches.Strategic approaches to unraveling genetic causes of cardiovascular diseases.Proteasome functional insufficiency in cardiac pathogenesis.Molecular genetic studies of complex phenotypes.Unravelling fears of genetic discrimination: an exploratory study of Dutch HCM families in an era of genetic non-discrimination acts.Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy.Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activityEnhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin CThe costamere bridges sarcomeres to the sarcolemma in striated muscle.miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy.Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.Mechanisms of disease: hypertrophic cardiomyopathy.Hypertrophic Cardiomyopathy in a Young Adult with RV Aneurysm: Report of a Rare Finding and Review of the LiteratureGenetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy.Clinical utility gene card for: hypertrophic cardiomyopathy (type 1-14)Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.New approaches to prevent LEOPARD syndrome-associated cardiac hypertrophy by specifically targeting Shp2-dependent signaling.Hypertrophic cardiomyopathy and planned in vitro fertilization. Genetic testing and clinical evaluation.Vps34 regulates myofibril proteostasis to prevent hypertrophic cardiomyopathyHypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.Familial cardiomyopathy in Norwegian Forest cats.Risk of cardiovascular disease in family members of young sudden cardiac death victims.Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement.Drosophila in the Heart of Understanding Cardiac Diseases: Modeling Channelopathies and Cardiomyopathies in the Fruitfly.Myosin Rod Hypophosphorylation and CB Kinetics in Papillary Muscles from a TnC-A8V KI Mouse Model.Implanted defibrillators in young hypertrophic cardiomyopathy patients: a multicenter study.Essential light chain S195 phosphorylation is required for cardiac adaptation under physical stress.Letter to the Editor: Contemporary Screening and Treatment of Hypertrophic Cardiomyopathy.MRI classification of asymmetric septal hypertrophic cardiomyopathy and its relation to the presence of risk factors
P2860
Q24305518-2A054848-396F-486D-AD50-DEDEDFC8230BQ27021582-C20880B9-01E3-4D54-8DA0-6C50DF13816CQ28066435-27A3216E-2075-4DE7-A4CC-66E758D2AD8BQ28304022-DA4DE561-4784-4F7F-B018-D4544A707530Q30430827-0E47DD16-D49F-47AB-8B1A-F4459480F079Q33580919-77256B8E-836D-48A7-8DCC-0A987BA22DBBQ33812953-96496953-D88B-420A-A053-CDA48560D4C2Q33812972-D718390E-C8B4-4BA9-B0CA-E7AA6B5C518EQ34735798-D5204EC8-18FA-44E2-AC69-9D8B72DEF51EQ35047843-46205BE6-7B56-4B5C-B898-90376FE83B3CQ35601400-C7DE2D3E-1C35-4C01-9E71-05AE75C40067Q35676062-CC97F37E-AF13-4231-BEAC-AAF238C9D5BFQ36253410-269CB2B1-1444-4C28-96AE-77AD0CBA0043Q36350821-01FA7DF0-FFD5-4157-AD85-6B07B0D8DA7EQ36481336-DE9C8BE6-DFD5-433D-999E-850B05BE0714Q36984342-54C3A68A-0505-40D2-8B25-13559AC3BFFAQ37163710-5DCC916C-4D2A-43A1-AFF1-EEAB5D8D6F61Q37204328-6CD4E777-F8E1-4AE4-AF93-60FD7C0733D9Q37867324-F6B5B6B6-B94E-44CE-93D4-CE9989EC2CF3Q37949516-0DB7DCA3-1C16-4513-9232-EFCCFDE81576Q38008386-5948FC6A-D442-4282-B578-04C350B35244Q38261314-90CA95A4-0A92-4ADC-B78D-E9C53064B6FDQ38413180-416E3FBB-A8BC-4C23-AD37-313C41C53DF1Q39050554-899BA9CF-BFB3-49D7-AAFF-0DEBF401B665Q39419046-17310E0A-79F5-417F-85EC-2ACED0C2B207Q39657112-F910DDD1-74C1-4C51-98BA-75CC6ED2DBB1Q40765741-6CF8DCF6-D3AA-42D2-B215-E95D4B9236F4Q42515078-7DBD26A6-E7F5-4285-8EAB-6E2C7B247353Q42691104-5EB29289-7573-49F7-8347-90F640B3C6B2Q44674558-13C8BA13-4B9F-455D-9316-4E834025AC05Q46269501-5B4C7528-C3F5-409C-8149-12993EC3EE6AQ49415841-479A7E18-C1C7-4064-B25C-0E37B30B7113Q51033685-E988B353-C2B2-4389-9302-41AC792584EBQ51210207-7DA4C90A-1D1C-4B6B-AD44-637D216C4EADQ53139214-A0FCAA04-58EB-401F-AB3E-6FA3049DD63BQ55005588-E3007925-0D9A-4E3C-A1C9-19AF45A02A40Q58376931-3C7DB89C-45BE-43BB-8213-1385BC972C04
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hypertrophic cardiomyopathy: from genetics to treatment
@ast
Hypertrophic cardiomyopathy: from genetics to treatment
@en
type
label
Hypertrophic cardiomyopathy: from genetics to treatment
@ast
Hypertrophic cardiomyopathy: from genetics to treatment
@en
prefLabel
Hypertrophic cardiomyopathy: from genetics to treatment
@ast
Hypertrophic cardiomyopathy: from genetics to treatment
@en
P2860
P1476
Hypertrophic cardiomyopathy: from genetics to treatment
@en
P2093
Ali J Marian
P2860
P304
P356
10.1111/J.1365-2362.2010.02268.X
P577
2010-04-01T00:00:00Z